Technology
Scientific Data
Based on published literature and extensive research that we conducted on symptomatic and asymptomatic patients and a variety of pulmonary upper tract diseases and infection, Breath of Health has been able to identify the specific COVID19 markers. We filtered all additional markers that were present due to other conditions, and background diseases such as diabetes etc. By cross-referencing and analysis of the data, we are able to identify several wavelengths in the FTIR that are the most important for identification of a COVID19 Infection.
Clinical Research
Clinical research is an ongoing effort at Breath of Health.
Breath of Health is currently conducting clinical trials, which have been approved by the Ministry of Health at Shiba Tel Hashomer and Hadassah Hospitals. Other research and studies are being conducted in other world-renowned medical centers around the globe
With our fixed algorithm, our mid-term results show that we have achieved a correlation of 96.33%.
We were also able to achieve accurate correlation to the CT (cycle threshold) value of the subjects that tested positive to COVID19.
The points on the chart represent the BOH calculations based on FTIR readings and correlated to a central line of the actual CT readings of these test results.
We chose to use the FTIR (Fourier-transform infrared spectroscopy) as our analytic system because of its availability, sensitivity, mobility and simplicity of operation thus adding another limiting factor to our choice of markers, to markers that are easily detectable by the FTIR.
Our algorithm has achieved a repeatable and stable correlation of 96.33% compared to GeneXpert Systems and NeuMoDx Molecular, Inc. PCR’s positive and negative results. We were also able to achieve accurate correlation to the CT (cycle threshold) value of the subjects that tested positive to COVID19.
There are many advantages with analyzing breath and OCs, which include the following:

Non invasive and less strenuous sampling for subjects

Unlimited samples of breath gas allowing the collection of many samples per day

Free from biological and cellular material

Direct access to the lungs and indirect access to the systemic circulation
COVID19 the Diagnostic Challenge
The symptoms of COVID19 can resemble those of many other Diseases, making diagnostic tests essential.
Testing for the virus RNA, cannot determine whether someone has recovered; potentially miss the virus if in low levels in a patient.
Tests for antibodies or immune response cannot confirm the presence of Virus and different people can have different antibody responses to COVID19.
Advantages
Takes 45 seconds
Low Cost Test
Contains AI algorithm for maximum accuracy
Diagnoses Symptomatic and Asymptomatic patients
Open API – connects to any system, Provides reports
